Biotech News

2 weeks This Beaten-Down Stock Could Soar by 354%, According to Wall StreetThe Motley Fool X

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

3 weeks Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO24/7 Wall St. X

3 weeks Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

3 weeks ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting DebacleInvestor's Business Daily X

3 weeks Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars LoomInvestor's Business Daily X

3 weeks This High-Flying Stock Just Became a Better BuyThe Motley Fool X

3 weeks Why Guardant Health Stock Was the Picture of Health TodayThe Motley Fool X

3 weeks Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7%MarketBeat X

3 weeks Harmony Bio, The No. 1 Biotech Stock, Surges On Its ‘High Quality’ BeatInvestor's Business Daily X

3 weeks Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

3 weeks Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?Zacks X

3 weeks Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

4 weeks Novo Holdings A S Has $3.52 Million Position in IO Biotech, Inc. (NASDAQ:IOBT)MarketBeat X

4 weeks Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short InterestMarketBeat X

4 weeks 3 Key Trends That Are Bullish for Recursion Pharmaceuticals StockThe Motley Fool X

4 weeks The Ultimate Biotech Stock to Buy With $50 Right NowThe Motley Fool X

4 weeks Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of “Buy” from AnalystsMarketBeat X

4 weeks U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small NamesSeeking Alpha X

4 weeks Why Intellia Therapeutics Stock Plummeted by 20% TodayThe Motley Fool X

4 weeks Why Viking Therapeutics Stock Soared by Nearly 21% on ThursdayThe Motley Fool X

4 weeks XBI: Biotech ETF Is A Must HaveSeeking Alpha X

4 weeks Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its ‘Impressive’ ResultsInvestor's Business Daily X

4 weeks Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug loomsMarketWatch X

4 weeks 5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks X

4 weeks What sector do you think will be the next bubble?Reddit X

4 weeks 1 Brand-New Big Reason to Buy This Biotech Stock Right NowThe Motley Fool X

4 weeks Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech InnovationInsider Monkey X

4 weeks Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical ResultsInsider Monkey X

4 weeks Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales GrowthInsider Monkey X

4 weeks Arvinas (ARVN): A Small-Cap Biotech with High Growth PotentialInsider Monkey X

4 weeks Legend Biotech (NASDAQ:LEGN) Shares Gap Up – Here’s WhyMarketBeat X

4 weeks Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of CashSeeking Alpha X

1 month Should You Invest in the VanEck Biotech ETF (BBH)?Zacks X

1 month Everence Capital Management Inc. Invests $557,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)MarketBeat X

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X

1 month This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?The Motley Fool X

1 month Q3 EPS Estimates for Legend Biotech Boosted by HC WainwrightMarketBeat X

1 month Warren Buffett and Biotech IPOs Highlight Recent Insider Buying24/7 Wall St. X

1 month How Bad Is This News for Novavax?The Motley Fool X

7 months Can biotech startups upstage Eli Lilly and Novo Nordisk?The Economist X